Search

Your search keyword '"Lomakin, Y"' showing total 96 results

Search Constraints

Start Over You searched for: Author "Lomakin, Y" Remove constraint Author: "Lomakin, Y"
96 results on '"Lomakin, Y"'

Search Results

3. A precise measurement of 180 GeV muon energy losses in iron

6. Measurement of pion and proton response and longitudinal shower profiles up to 20 nuclear interaction lengths with the ATLAS Tile calorimeter

7. Testbeam studies of production modules of the ATLAS Tile Calorimeter

8. “Shielding” of Cytokine Induction by the Periodontal Microbiome in Patients with Periodontitis Associated with Type 2 Diabetes Mellitus

10. Divergent immunomodulation capacity of individual myelin peptides-components of liposomal therapeutic against multiple sclerosis

11. Analysis of Immunogenicity of Intracellular CTAR Fragments of Epstein—Barr Virus Latent Phase Protein LMP1

12. Single-Molecule Interactions of a Monoclonal Anti-DNA Antibody with DNA

13. Peptides against autoimmune neurodegeneration

14. Exposure to the Epstein-Barr viral antigen latent membrane protein 1 induces myelin-reactive antibodies in vivo

16. Polyreactive Monoclonal Autoantibodies in Multiple Sclerosis: Functional Selection from Phage Display Library and Characterization by Deep Sequencing Analysis

17. Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF- α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients

18. CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study

19. Myelin-Reactive Monoclonal Antibodies from Multiple Sclerosis Patients Cross-React with Nucleoproteins in HEp-2 Lysate

20. Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity

21. The optical instrumentation of the ATLAS Tile Calorimeter

22. Mechanical construction and installation of the ATLAS tile calorimeter

23. Testbeam studies of production modules of the ATLAS Tile Calorimeter

24. The Production and Qualification of Scintillator Tiles for the ATLAS Hadronic Calorimeter

25. The ATLAS hadronic Tile Calorimeter: From construction toward physics

26. A measurement of the photonuclear interactions of 180 GeV muons in iron: The tilecal system of the ATLAS collaboration

27. A measurement of the photonuclear interactions of 180 GeV muons in iron

28. The optical instrumentation of the ATLAS Tile Calorimeter

29. Mechanical construction and installation of the ATLAS tile calorimeter

30. A precise measurement of 180 GeV muon energy losses in iron

31. ATLAS detector and physics performance: Technical Design Report, 2

32. ATLAS detector and physics performance: Technical Design Report, 1

33. Hadronic Shower Development in Iron-Scintillator Tile Calorimetry

34. Mechanical construction and installation of the ATLAS tile calorimeter

35. The optical instrumentation of the ATLAS Tile Calorimeter

36. Results from a combined test of an electromagnetic liquid argon calorimeter with a hadronic scintillating-tile calorimeter

37. MEASUREMENT OF DALITZ PLOT SLOPE PARAMETERS FOR K+ → π+π0π0 DECAY.

39. Expression of Interest by the Solenoidal Detector Collaboration to Construct and Operate A Detector at the Superconducting Super Collider

40. ATLAS: Detector and physics performance technical design report. Volume 2

41. A precise measurement of 180 GeV muon energy losses in iron

42. Letter of Intent by the Solenoidal Detector Collaboration to Construct and Operate A Detector at the Superconducting Super Collider

43. CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study

44. CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study

45. Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF- α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients

46. Mediators and biomarkers of inflammation in meningitis: Cytokine and peptidome profiling of cerebrospinal fluid

47. Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity

48. CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study

49. Mediators and biomarkers of inflammation in meningitis: Cytokine and peptidome profiling of cerebrospinal fluid

50. CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study

Catalog

Books, media, physical & digital resources